Rhythm Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+2.92%
vs ±11.3% implied · ×0.26
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
Rhythm Pharmaceuticals, Inc.
91.74
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $740.2M | 8.61% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $683.6M | 7.95% | −1.29% | |
| 3 | Baker Bros. AdvisorsBaker Bros. | $622.3M | 7.24% | 0.00% | |
| 4 | Primecap ManagementPrimecap | $351.8M | 4.09% | −7.28% | |
| 5 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $348.3M | 4.05% | +3.16% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $333.8M | 3.88% | +1.29% | |
| 7 | JPMorgan ChaseJPMorgan Chase | $292.2M | 3.40% | +70.74% | |
| 8 | Perceptive AdvisorsPerceptive | $287.2M | 3.34% | +8.95% | |
| 9 | State StreetState Streetindex-like | $285.7M | 3.32% | +13.28% | |
| 10 | T. Rowe Price AssociatesT. Rowe Price | $284.9M | 3.31% | +55.07% | |
| 11 | Westfield Capital ManagementWestfield | $245.2M | 2.85% | +14.49% | |
| 12 | Goldman Sachs GroupGoldman Sachs | $236.1M | 2.75% | +8.20% | |
| 13 | Federated InvestorsFederated Investors | $198.3M | 2.31% | +38.83% | |
| 14 | Polar Capital HoldingsPolar Capital | $184.7M | 2.15% | +2.97% | |
| 15 | Geode Capital ManagementGeodeindex-like | $170.3M | 1.98% | +8.29% | |
| 16 | Capital Research Global InvestorsCapital Research Global Investors | $170.1M | 1.98% | +37.37% | |
| 17 | Citadel AdvisorsCitadel | $145.4M | 1.69% | −9.90% | |
| 18 | Checkpoint CapitalCheckpoint Capital | $131.7M | 1.53% | −3.36% | |
| 19 | SirenSiren | $126.2M | 1.47% | +56.62% | |
| 20 | Morgan StanleyMorgan Stanley | $123.5M | 1.44% | +57.99% | |
| 21 | FMRFMR | $113.9M | 1.32% | −39.29% | |
| 22 | Pictet Asset Management HoldingPictet | $106.3M | 1.24% | +43.59% | |
| 23 | Jupiter TopcoJupiter Topco | $102.8M | 1.19% | — | |
| 24 | AlliancebernsteinAlliancebernstein | $99.3M | 1.16% | −1.72% | |
| 25 | Woodline PartnersWoodline Partners | $84.3M | 0.98% | 0.00% |
305 managers report $8.6B of Rhythm Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 31 of them hold 80% of it; RA Capital Management is largest at 8.61%.
No implied move.
No implied move.
Expected move
No implied move.